Conclusion
Although IL 1 and TNF are biochemically distinct and bind to different cell membrane receptors, they each exhibit only a few distinct biological properties, and have a great number of activities in common. Thus, IL 1 and TNF are radioprotective, have cytocidal effects for some tumor cells, remodel bone and cartilage, induce fever, inflammation, fibroplasia, and angiogenesis. The overlapping effects of IL 1 and TNF are in part due to the induction of the same spectrum of cytokines and their receptors. Both IL 1 and TNF induce IL 2-receptors, IL 6, colony stimulating factors and acute phase proteins which may contribute to their immunoenhancing, inflammatory and radioprotective effects. IL 1 and TNF frequently also are coordinately released by cells and have cooperative effects. For example, IL 1 together with TNF has synergisticin vivo radioprotective effects andin vitro terminal differentiative effects on tumor cell lines. Overall, these data point to the existence of common as well as distinct post-receptor signal transduction pathways for IL 1 and TNF. IL 1 and TNF each can induce a number of cell types to produce IL 6, which appears to act as another “broad spectrum” cytokine. In addition, both IL 1 and TNF induce NAP-1 production by human monocytes and fibroblasts. This novel cytokine which has been purified, sequenced, cloned, expressed and synthesized, may account for some of thein vivo acute inflammatory effects of these cytokines.
Similar content being viewed by others
References
J. Le and J. Vilcek,TNF and IL 1: Cytokines with multiple overlapping biological activities. Lab. Invest.56, 234–282 (1987).
S. K. Durum, J. A. Schmidt and J. J. Oppenheim,Interleukin 1: An immunological perspective. Ann. Rev. Immunol.3, 263–287 (1985).
J. J. Oppenheim, E. J. Kovacs, K. Matsushima and S. K. Durum,There is more than on interleukin 1. Immunol. Today7, 45 (1986).
S. L. Koide, K. Inaba and R. M. Steinman,Interleukin 1 enhances T-dependent immune responses by amplifying the function of dendritic cells. J. Exp. Med.165, 515 (1987).
P. Scheurich, B., Thoma, U. Ucer and K. Pfizenmaier,Immuno-regulatory activity of recombinant human TNFα: Induction of TNF receptors on human T cells and TNFα mediated enhancement of T cell responses. J. Immunol.138, 1786–1791 (1987).
J. H. Kehrl, A. Miller and A. S. Fauci,Effect of tumor necrosis factor alpha on mitogen-activated human B cells. J. Exp. Med.166, 781–791 (1987).
P. ghiara, D. Boraschi, L. Nencioni, P. Ghezzi and A. Tagliabue,Enhancement of in vivo immune response by tumor necrosis factor. J. Immunol.139, 3678–3679 (1987).
T. Yoshimura, K. Matsushima. J. J. Oppenheim and E. J. Leonard,Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: Partial characterization and separation from interleukin 1 (IL1). J. Immunol.139, 788 (1987).
P. Peveri, A. Walz, B. Dewald and M. Baggiolini,A novel neutrophil activating factor produced by human mononuclear phagocytes. J. Exp Med., in press (1988).
M. Tsujumoto, S. Yokota, J. Vilcek and G. Weissman,Tumor necrosis factor provokes superoxide anion generation from neutrophils. Biochem. Biophys. Res. Commun.137, 1094 (1986).
S. J. Klebanoff, M. A. Vadas, J. M. Harlan, L. J. Sparks, J. R. Gamble, J. M. Agosti and A. M. Waltersdorph,Stimulation of neutrophils by tumor necrosis factor. J. Immunol.36, 4220 (1986).
J. Van Damme, G. Opdenakker, R. Simpson, M. Rubira, S. Cayphas, A. Vink, A. Billiau and J. Van Snick,Identification of the human 26-kD protein, interferon Beta-2, as a B cell hybridome/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. J. Exp. Med.165, 914–919 (1987).
K. Matsushima, K. Morishita, T. Yoshimura, S. Lavu, Y. Kobayashi, W. Lew, E. Appella, H-F. Kung, E. J. Leonard and J. J. Oppenheim,Molecular cloning of a human monocyte derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCFmRNA by interleukin 1 and tumor necrosis factor. J. Exp. Med., in press.
J. S. Pober, M. A. Jr. Gimbrone, L. A. Lapierre, D. L. Mendrick, W. Fiers, R. Rothlein and T. A. Springer,Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor and immune interferon. J. Immunol.137, 1893 (1986).
M. Rampart, W. Fiers and A. G. Herman,Different inflammatory profiles of IL 1 and TNF in raffit skin in vivo. Agents and Actions, in press.
C. J. Dunn, M. H. Hardee, A. J. Gibbons, N. D. Staite and K. A. Richards,IL 1 induces chronic inflammation. InProc 2nd Intl. Workshop on Monkines and Non-Lymphocytic Cytokines. (Eds. M. Powanda, J. J. Oppenheim, M. Kluger and C. A. Dinarello) Alan R. Liss, New York, in press (1988).
M. P. Bevilaqua, J. S. Pober, G. R. Mageau, W. Fiers, R. S. Cotran and M. A. Gimbrone,Recombinant tumor necrosis factor induces procoagulant activity in cultures human vascular endothelium: Characterization and coparison with the actions of interleukin 1. Proc. Natl. Acad. Sci. USA83, 4533 (1986).
P. P. Nawroth and D. M. Stern,Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J. Exp. Med.163, 740 (1986).
E. A. Carswell, L. J. Old, R. L. Kassel, S. Green, N. Fiore and B. Williamson,An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA72, 3666 (1975).
B. Beutler and A. Cerami,Cachectin and TNF as two sides of the same biological coin. Nature320, 584 (1986).
G. Beck, S. G. Habicht, J. L. Benach and F. Miller,IL 1: A common endogenous mediator of inflammation and the local Schwartzmann reaction. J. Immunol.136, 3025 (1986).
F. Berkenbosch, J. Van Oers, A. Del Rey, F. Tilders and H. Besedovsky,Corticotropin-releasing factor producing neurons in the rat activated by IL 1. Science238, 524 (1987).
W. Lew, J. J. Oppenheim and K. Matsushima,Analysis of the suppression of interleukin 1α and β production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone. J. Immunol., in press.
T. Akahosi, J. J. Oppenheim and K. Matsushima,Induction of high affinity interleukin 1 receptor on human peripheral blood lymphocytes by glucocorticoid hormones. J. Exp. Med., in press.
J. J. Oppenheim, T. Akahoshi, K. Matsushima and G. Tosato,Modulation of IL 1 receptor expression by IL 1, prostaglandins and glucocorticoids. InProc of the 18th Intl. Leucocyte Culture Conference. (Eds. J-C. Mani and G. Dornan). Walter DeGruyter, in press.
D. R. Bertolini, G. E. Nedwin, T. S. Bringman, D. D. Smith and G. R. Mundy,Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature319, 516 (1986).
C. Peetre, U. Gullberg, E. Nilsson and I. Olsson,Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. J. Clin. Invest.78, 1694 (1986).
R. Neta, J. J. Oppenheim and S. D. Douches,Interdependence of the radioprotective effects of human recombinant interleukin-1α, tumor necrosis factor α, granulocyte colony stimulating factor and murine recombinant granulocyte-macrophage colony stimulating factor. J. Immunol.140, 108 (1988).
K. Onozaki, H. Urawa, T. Tamatani, Y. Iwamura, T. Hashimoto, T. Baba, H. Suzuki, M. Yamada, S. Yamamoto, J. J. Oppenheim and K. Matsushima,Synergistic interactions of interleukin 1, interferon-β and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1): Evidence that interferon-β is an autocrine differentiating factor. J. Immunol.140, 112 (1988).
K. Onozaki, K. Matsushima, B. B. Aggarwal and J. J. Oppenheim,Human interleukin 1 is a cytocidal factor for several tumor cell lines. J. Immunol.135, 3962 (1985).
R. Nordan and M. Potter,A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science233, 566 (1986).
J. Gauldie, C. Richards, S. Harnish, P. Lansdorp and H. Baumann,Interferon beta-2/B cell stimulatory factor Type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Natl. Acad. Sci. USA84, 7251 (1987).
P. G. Coulie, A. Vanhecke, J. Van Damme, S. Cayphas, P. Poupart, L. DeWit and J. Content,High-affinity binding sites for human 26-kDa protein (interleukin 6, B cell stimulatory factor-2, interferon-beta 2),different from those of type I interferon (alpha, beta) on lymphoblastoid cells. Eur. J. Immunol.17, 1435 (1987).
T. A. Luger, J. A. Charon, M. Colot, M. Micksche and J. J. Oppenheim,Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear mononuclear cells. J. Immunol.132, 828 (1983).
T. Yoshimura, K. Matsushima, S. Tanaka, E. A. Robinson, E. Appella, J. J. Oppenheim and E. J. Leonard,Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl. Acad. Sci. USA84, 9233 (1987).
S. M. Schroeder, U. Mrowietz, E. Morita and E. Christophers,Purification and partial biochemical characterization of a human monocyte-derived neutrophil-activating peptide that lacks IL 1 activity. J. Immunol.139, 3474 (1987).
J. Schmid and C. Weissmann,Induction of mRNA for a serine protease and α, β thromboglobulin-like protein in mitogenstimulated human leukocytes. J. Immunol.139, 250 (1987).
J. C. Holt, M. E. Harris, A. M. Holt, E. Lange, A. Henschen and S. Niewiarowski,Characterization of human platelet basic protein, a precursor form of low affinity platelet factor 4 and β thromboglobulin. Biochemistry25, 1988 (1986).
G. Kaplan, A. D. Luster, G. Hancock and Z. A. Cohn,The expression of gamma interferon-induced protein (IP-10) in delayed immune responses in human skin. J. Exp. Med.166, 1098 (1987).
S. Sugano, M. Y. Stoeckle and H. Hanafusa,Transformation by Rous sarcoma virus induces a novel gene with homology to a mitogenic platelet protein. Cell49, 321 (1987).
A. Anisowicz, L. Bardwell and R. Sager,Constitutive over-expression of a growth-regulated gene in transformed Chinese hamster and human cells. Proc. Natl. Acad. Scin USA84, 7188 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oppenheim, J.J., Matsushima, K., Yoshimura, T. et al. Relationship between interleukin 1 (IL1), tumor necrosis factor (TNF) and a neutrophil attracting peptide (NAP-1). Agents and Actions 26, 134–140 (1989). https://doi.org/10.1007/BF02126586
Issue Date:
DOI: https://doi.org/10.1007/BF02126586